Anahita Jalilvand, Patrick J Kennedy, John Loftus, Courtney Collins, Whitney Kellett, Wendy Wahl, Jon Wisler
{"title":"入院前减肥手术与脓毒症手术患者死亡率降低相关","authors":"Anahita Jalilvand, Patrick J Kennedy, John Loftus, Courtney Collins, Whitney Kellett, Wendy Wahl, Jon Wisler","doi":"10.1097/SHK.0000000000002568","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Obesity is associated with higher 90-day mortality compared to non-obese surgical patients. Bariatric surgery (BS) can reduce obesity-related comorbidities, even in those with persistent obesity.</p><p><strong>Objective: </strong>Evaluate the impact of prior BS on sepsis outcomes in surgical patients with obesity.SettingUniversity Hospital, United States.</p><p><strong>Methods: </strong>A single institution retrospective review of all surgical patients with sepsis (SOFA≥2) was conducted. Patients were grouped into people with obesity and prior BS (OB/BS, n = 48), people with obesity without BS (OB, n = 717), non-obese (NOB, n = 574), and non-obese with prior BS (NOB/BS, n = 27). Demographic data, comorbidities, and sepsis presentation were compared. The primary outcome was cumulative 90-day mortality and survival.</p><p><strong>Results: </strong>Most OB/BS patients underwent gastric bypass <5 years from admission (61%). The OB/BS group was younger, more likely to be female, and transferred from an outside hospital. The mean BMI was highest in the OB/BS group (46.3±14.7, p < 0.0005). Charlson Comorbidity Index was lower in the OB/BS and NOB/BS groups (2 (1-4) and 2(2-4) respectively, p = 0.0033). Cumulative 90-day mortality was significantly lower in the OB/BS cohort (20.8%, p = 0.002). The OB/BS cohort was more likely to die from intra-abdominal sepsis not amenable to source control (60% vs 22.5% vs 22.8% vs 37.5%, p = 0.04). Compared to the other groups, 90-day survival was highest in the OB/BS cohort (logrank p < 0.009).</p><p><strong>Conclusions: </strong>This study demonstrated improvement in 90-day survival in OB/BS patients despite higher BMIs. However, this group was more likely to die from intra-abdominal sources, likely reflecting surgical complexity in the setting of prior bypasses.</p>","PeriodicalId":21667,"journal":{"name":"SHOCK","volume":" ","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pre-Admission Bariatric Surgery is Associated with Reduced Mortality in Surgical Patients with Sepsis.\",\"authors\":\"Anahita Jalilvand, Patrick J Kennedy, John Loftus, Courtney Collins, Whitney Kellett, Wendy Wahl, Jon Wisler\",\"doi\":\"10.1097/SHK.0000000000002568\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Obesity is associated with higher 90-day mortality compared to non-obese surgical patients. Bariatric surgery (BS) can reduce obesity-related comorbidities, even in those with persistent obesity.</p><p><strong>Objective: </strong>Evaluate the impact of prior BS on sepsis outcomes in surgical patients with obesity.SettingUniversity Hospital, United States.</p><p><strong>Methods: </strong>A single institution retrospective review of all surgical patients with sepsis (SOFA≥2) was conducted. Patients were grouped into people with obesity and prior BS (OB/BS, n = 48), people with obesity without BS (OB, n = 717), non-obese (NOB, n = 574), and non-obese with prior BS (NOB/BS, n = 27). Demographic data, comorbidities, and sepsis presentation were compared. The primary outcome was cumulative 90-day mortality and survival.</p><p><strong>Results: </strong>Most OB/BS patients underwent gastric bypass <5 years from admission (61%). The OB/BS group was younger, more likely to be female, and transferred from an outside hospital. The mean BMI was highest in the OB/BS group (46.3±14.7, p < 0.0005). Charlson Comorbidity Index was lower in the OB/BS and NOB/BS groups (2 (1-4) and 2(2-4) respectively, p = 0.0033). Cumulative 90-day mortality was significantly lower in the OB/BS cohort (20.8%, p = 0.002). The OB/BS cohort was more likely to die from intra-abdominal sepsis not amenable to source control (60% vs 22.5% vs 22.8% vs 37.5%, p = 0.04). Compared to the other groups, 90-day survival was highest in the OB/BS cohort (logrank p < 0.009).</p><p><strong>Conclusions: </strong>This study demonstrated improvement in 90-day survival in OB/BS patients despite higher BMIs. However, this group was more likely to die from intra-abdominal sources, likely reflecting surgical complexity in the setting of prior bypasses.</p>\",\"PeriodicalId\":21667,\"journal\":{\"name\":\"SHOCK\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-03-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"SHOCK\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/SHK.0000000000002568\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CRITICAL CARE MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"SHOCK","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/SHK.0000000000002568","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0
摘要
背景:与非肥胖手术患者相比,肥胖与更高的90天死亡率相关。减肥手术(BS)可以减少肥胖相关的合并症,即使对那些持续肥胖的人也是如此。目的:评价既往BS对手术合并肥胖患者脓毒症结局的影响。SettingUniversity医院,美国方法:对所有脓毒症手术患者(SOFA≥2)进行单机构回顾性分析。患者分为肥胖合并既往BS患者(OB/BS, n = 48)、肥胖合并BS患者(OB, n = 717)、非肥胖患者(NOB, n = 574)和非肥胖合并既往BS患者(NOB/BS, n = 27)。比较人口学数据、合并症和败血症的表现。主要终点为累计90天死亡率和生存率。结果:大多数OB/BS患者接受了胃分流术。结论:该研究表明,尽管bmi较高,OB/BS患者的90天生存率仍有改善。然而,该组更有可能死于腹腔内源,可能反映了先前旁路手术的复杂性。
Pre-Admission Bariatric Surgery is Associated with Reduced Mortality in Surgical Patients with Sepsis.
Background: Obesity is associated with higher 90-day mortality compared to non-obese surgical patients. Bariatric surgery (BS) can reduce obesity-related comorbidities, even in those with persistent obesity.
Objective: Evaluate the impact of prior BS on sepsis outcomes in surgical patients with obesity.SettingUniversity Hospital, United States.
Methods: A single institution retrospective review of all surgical patients with sepsis (SOFA≥2) was conducted. Patients were grouped into people with obesity and prior BS (OB/BS, n = 48), people with obesity without BS (OB, n = 717), non-obese (NOB, n = 574), and non-obese with prior BS (NOB/BS, n = 27). Demographic data, comorbidities, and sepsis presentation were compared. The primary outcome was cumulative 90-day mortality and survival.
Results: Most OB/BS patients underwent gastric bypass <5 years from admission (61%). The OB/BS group was younger, more likely to be female, and transferred from an outside hospital. The mean BMI was highest in the OB/BS group (46.3±14.7, p < 0.0005). Charlson Comorbidity Index was lower in the OB/BS and NOB/BS groups (2 (1-4) and 2(2-4) respectively, p = 0.0033). Cumulative 90-day mortality was significantly lower in the OB/BS cohort (20.8%, p = 0.002). The OB/BS cohort was more likely to die from intra-abdominal sepsis not amenable to source control (60% vs 22.5% vs 22.8% vs 37.5%, p = 0.04). Compared to the other groups, 90-day survival was highest in the OB/BS cohort (logrank p < 0.009).
Conclusions: This study demonstrated improvement in 90-day survival in OB/BS patients despite higher BMIs. However, this group was more likely to die from intra-abdominal sources, likely reflecting surgical complexity in the setting of prior bypasses.
期刊介绍:
SHOCK®: Injury, Inflammation, and Sepsis: Laboratory and Clinical Approaches includes studies of novel therapeutic approaches, such as immunomodulation, gene therapy, nutrition, and others. The mission of the Journal is to foster and promote multidisciplinary studies, both experimental and clinical in nature, that critically examine the etiology, mechanisms and novel therapeutics of shock-related pathophysiological conditions. Its purpose is to excel as a vehicle for timely publication in the areas of basic and clinical studies of shock, trauma, sepsis, inflammation, ischemia, and related pathobiological states, with particular emphasis on the biologic mechanisms that determine the response to such injury. Making such information available will ultimately facilitate improved care of the traumatized or septic individual.